Viking Therapeutics Financial Overview
Viking Therapeutics's market cap is currently $3.98B. The company's EPS TTM is $-0.81; its P/E ratio is -16.61; Viking Therapeutics is scheduled to report earnings on October 22, 2025, and the estimated EPS forecast is $-0.90. See an overview of income statement, balance sheet, and cash flow financials.
